Novo Nordisk A/S: all 1,444 studies

Page 5 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesCompletedNCT00469092Phase 4Results posted
• Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCompletedNCT00455858Phase 4Results posted
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedNCT00447382Phase 3Results posted
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT00435019Phase 3Results posted
• Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic VaginitisCompletedNCT00431132Phase 3Results posted
• The Effect of Liraglutide on Body Weight in Obese Subjects Without DiabetesCompletedNCT00422058Phase 2Results posted
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00395746Phase 3Results posted
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00393718Phase 3Results posted
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherCompletedNCT00318461Phase 3Results posted
• To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cTerminatedNCT00294723Phase 3Results posted
• Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)CompletedNCT00184717Phase 3Results posted
• Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 DiabetesCompletedNCT00184600Phase 3Results posted
• Evaluation of Recombinant Factor VIIa in Patients With Severe BleedingTerminatedNCT00184548Phase 3Results posted
• Real-World Patient and Physician Experience With Semaglutide Across Six Emerging MarketsCompletedNCT07850765
• A Retrospective Real-World Cohort StudyActive, not recruitingNCT07781371
• Korean Real-world Study on MASLD/MASH Outcomes.Active, not recruitingNCT07739901
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With ObesityActive, not recruitingNCT07639021Phase 2
• Weight Loss in Adults Using Semaglutide (Real-world Study)CompletedNCT07627074
• Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked HypophosphatemiaWithdrawnNCT07607600
• A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body WeightCompletedNCT07605052Phase 1
• A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body WeightActive, not recruitingNCT07525791Phase 1
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight LossActive, not recruitingNCT07503210Phase 3
• Current Status of Cardiovascular Diseases in Chinese Overweight/ Obesity Population: An Epidemiological Study (COPE）CompletedNCT07358052
• A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body WeightWithdrawnNCT07357766Phase 3
• A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 DiabetesWithdrawnNCT07357740Phase 2
• A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 DiabetesCompletedNCT07305805Phase 1
• A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 DiabetesCompletedNCT07271251Phase 3
• A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy PeopleCompletedNCT07238816Phase 1
• Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With CagrilintideActive, not recruitingNCT07220759Phase 3
• Weight Loss in People Living With Overweight or Obesity Following Treatment With CagrilintideActive, not recruitingNCT07220642Phase 3
• A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver FatActive, not recruitingNCT07214870Phase 1
• A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk PopulationCompletedNCT07201831
• A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityActive, not recruitingNCT07184632Phase 2
• A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to DietActive, not recruitingNCT07184086Phase 1
• Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure ManagementCompletedNCT07160829
• A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood SugarActive, not recruitingNCT07160816
• A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real WorldCompletedNCT07141914
• A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.CompletedNCT07121153Phase 1
• CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in IndiaCompletedNCT07121114
• A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or ObesityCompletedNCT07101783Phase 1
• A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesActive, not recruitingNCT07087795Phase 1
• A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).TerminatedNCT07081178
• A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesActive, not recruitingNCT07076199Phase 3
• A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin PumpCompletedNCT07068295Phase 1
• User Experience With DuraTouch® in Patients With Type 1 or Type 2 DiabetesCompletedNCT07052292
• A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy PeopleCompletedNCT07029568Phase 1
• A Study on the Effect of Etavopivat on Heart Rhythm in Healthy ParticipantsCompletedNCT07023029Phase 1
• A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termActive, not recruitingNCT07011667Phase 3
• A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body WeightCompletedNCT07004322Phase 1
• Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real WorldCompletedNCT06874751
• A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaActive, not recruitingNCT06859073Phase 1
• Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and VietnamCompletedNCT06843473
• A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral DosingCompletedNCT06820476Phase 1
• A Research Study of the Effect of Etavopivat on Other Drugs in Healthy ParticipantsCompletedNCT06813924Phase 1
• A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin PumpCompletedNCT06809621Phase 1
• A Study Collecting Remote Data in People With an Overweight Condition or Obesity on a Weight Management ProgramCompletedNCT06805539
• A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyCompletedNCT06797869Phase 2
• A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With ObesityActive, not recruitingNCT06780449Phase 3
• SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world DataCompletedNCT06769646
• A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up DatabaseCompletedNCT06741111
• A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or ObesityCompletedNCT06737536Phase 1
• A Study on How NNC0174-1213 Works in People With Overweight or Obesity.CompletedNCT06719011Phase 1
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or ObesityCompletedNCT06718998Phase 1
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or ObesityCompletedNCT06716307Phase 1
• A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesCompletedNCT06685185Phase 1
• Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney DiseaseCompletedNCT06655493
• A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy MenCompletedNCT06649630Phase 1
• A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IVCompletedNCT06642584Phase 1
• A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the MedicineCompletedNCT06642571Phase 1
• A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the SkinCompletedNCT06625307Phase 1
• Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting InsulinCompletedNCT06592950
• A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and NephrologistsCompletedNCT06589791
• Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese AdolescentsCompletedNCT06588504Phase 1
• A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese ParticipantsCompletedNCT06581627Phase 1
• A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or ObesityActive, not recruitingNCT06577766Phase 1
• Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A PatientsCompletedNCT06574984
• STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight LossActive, not recruitingNCT06571383Phase 4
• A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 DiabetesCompletedNCT06567041Phase 1
• A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedNCT06559527Phase 1
• A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 DiabetesCompletedNCT06542874Phase 2
• A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian MenCompletedNCT06542536Phase 1
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothCompletedNCT06534411Phase 3
• Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 DiabetesCompletedNCT06517784
• A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After MenopauseCompletedNCT06513104Phase 1
• Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 DiabetesCompletedNCT06507475
• A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or ObesityCompletedNCT06478563Phase 1
• A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This TreatmentCompletedNCT06478550
• A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become PregnantCompletedNCT06461039Phase 1
• A Research Study of the Effect of Food on Etavopivat in Healthy ParticipantsCompletedNCT06433661Phase 1
• Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseCompletedNCT06409130Phase 2
• Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 DiabetesCompletedNCT06403761Phase 1
• A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightCompletedNCT06388187Phase 3
• A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney FunctionCompletedNCT06370819Phase 1
• Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)CompletedNCT06351748
• A Research Study on Etavopivat in Participants With and Without Liver DiseaseCompletedNCT06336018Phase 1
• A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy PeopleCompletedNCT06336005Phase 1
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose WeightCompletedNCT06326060Phase 2
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 DiabetesCompletedNCT06326047Phase 2
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseCompletedNCT06323174Phase 3
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without MetforminCompletedNCT06323161Phase 3

← Novo Nordisk A/S overview and focus areas